secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2022-02-03T23:59:59+00:00
Accession:  0000947871-22-000132
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics appoints James E. Davis as CEO-elect; CFO Mark Guinan to retire in 2022
--------------------------------------------------------------------------------

- James E. Davis appointed CEO-elect effective Feb. 3, 2022; to become CEO and President on Nov. 1, 2022.
- Current CEO Steve Rusckowski to remain CEO through Oct. 2022 then serve as Executive Chairman through Mar. 2023.
- CFO Mark Guinan announces retirement in 2022; company begins search for successor.
- Davis currently EVP of General Diagnostics, overseeing >80% of $10.8B 2021 revenue.
- Transition reflects planned succession; no financial impact disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000094787122000132/0000947871-22-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000094787122000132/ss773888_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-22-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer